A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...
MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...
From consumer products to clinical ... while some patients may be able to participate in a study during the week, others may need to participate on weekends. All forms of engagement help, but ...
S.A., a global leader in AI-driven bone microarchitecture imaging solutions, proudly announces 510(k) clearance from FDA and ...
A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
In its drive to transform health care in the Tampa Bay region and beyond, Tampa General Hospital (TGH) has reached another milestone — a prestigious stamp of approval by the American Society of ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
TBS Osteo’s next generation expands fracture risk assessment ... and direct patient engagement. The science behind our cutting-edge imaging applications and clinical evidence forms the core ...
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback